October
10
  2:53:02 AM

Disbursing stem cell boodle

The California Institute for Regenerative Medicine will soon have US$3 billion to spend -- but it is already having trouble handing out the loot. One grant application has been withdrawn by the applicant and another grant rescinded by the CIRM after further investigation. One recipient, the CHA Regenerative Medicine Institute of Los Angeles, has turned down a $2.6 million grant following allegations of plagiarism. Another grant for $638,000 was approved, but a last-minute administrative check found that the principal investigator was not an on-site, full-time employee, as stipulated by the CIRM. Critics of the CIRM blame its secretive grant-award process for the mistakes.


 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Indian surrogate for US woman dies in Gurjarat
18 May 2012
Do reproductive rights survive gender reassignment?
19 May 2012
South African activists begin euthanasia campaign
19 May 2012
70 assisted suicides in Washington state in 2011
19 May 2012
Would-be grandparents pay for their daughters’ egg freezing
19 May 2012

 Tags
abortion, research, India, embryonic stem cells, informed consent, Down syndrome, Netherlands, sperm donation, Australia, organ trafficking, China, US, law, commercialization, bioethics, Canada, organ transplants, euthanasia, assisted suicide, organ donation, genetic testing, sex selection, suicide, surrogacy, IVF, stem cells, clinical trials, human drama, neuroscience, UK,